阿莫西林克拉维酸钾复方制剂在社区获得性肺炎治疗中的作用  

Role of Amoxicillin and Clavulanate Potassium in Treatment of Community-acquired Pneumonia

作　　者：唐晓燕[1] 

机构地区：[1]四川大学华西医院呼吸科,四川省成都市610041

出　　处：《中国全科医学》2012年第20期2330-2331,共2页Chinese General Practice

摘　　要：社区获得性肺炎(CAP)是临床常见的感染性疾病,在长期临床用药过程中,CAP的耐药性问题日益突出,阿莫西林克拉维酸钾复方制剂在CAP中的治疗地位由于其疗效显著而逐渐被肯定。阿莫西林克拉维酸钾复方制剂不同配比的给药方案抗菌疗效也不尽相同,本研究通过临床实验也给出了两者最佳配比。Community-acquired pneumonia（CAP）is a common infectious disease.Its resistance has become increasingly prominent in long-term clinical course of medication.Amoxicillin and clavulanate potassium has been recognized gradually due to its significant effect on CAP.Different matching dosage regimen has different antimicrobial efficacy.This paper gives 2 best matching dosage regimens by clinical trials.

关 键 词：社区获得性感染 肺炎 阿莫西林棒酸钾合剂 药代动力学 

分 类 号：R563.1[医药卫生—呼吸系统]